Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001221045 | SCV001393067 | likely pathogenic | Early infantile epileptic encephalopathy with suppression bursts | 2019-07-26 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has been observed to be de novo in an individual affected with SCN1A-related condition (Invitae). This variant is reported as two separate entries in the ExAC population database (c.5781A>T, absent and c.5782C>G, 0.6%). This variant, c.5781_5782delinsTG, is a complex sequence change that results in the deletion of 2 amino acids and insertion of 2 amino acids in the SCN1A protein (p.Arg1927_Arg1928delinsSerGly). |